SPC marks AT2 and cancer cells, whereas the pan-immune marker CD45 allows us to exclude macrophages, which are labeled alongside cancer cells by the MADM system (presumably through lentiviral Cre infection; Fig. 1e). Here, SFTPC is linked to cancer.